Regal Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,822
Closed -$4.55M 60
2024
Q1
$4.55M Buy
7,822
+3,835
+96% +$2.15M 0.46% 27
2023
Q4
$2.12M Sell
3,987
-4,495
-53% -$2.18M 0.23% 32
2023
Q3
$4.29M Sell
8,482
-2,210
-21% -$1.18M 0.96% 21
2023
Q2
$5.58M Buy
10,692
+4,500
+73% +$2.43M 1.21% 14
2023
Q1
$3.57M Buy
6,192
+1,600
+35% +$902K 0.7% 19
2022
Q4
$2.53M Sell
4,592
-608
-12% -$322K 0.59% 22
2022
Q3
$2.64M Hold
5,200
0.55% 21
2022
Q2
$2.83M Buy
+5,200
New +$2.86M 0.48% 23

Other funds holding TMO

Regal Partners's TMO Position: Q2 2024 in Review

Regal Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2024, closing a stake of 7,822 shares — an estimated $4.55M sold.

Regal Partners first reported a position in TMO in Q2 2022 and held it in 8 quarters. The position peaked at $5.58M in Q2 2023. 2,542 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Regal Partners reported no remaining Thermo Fisher Scientific position as of Q2 2024 after selling out during the quarter.
  • Regal Partners sold 7,822 Thermo Fisher Scientific shares in Q2 2024, an estimated $4.55M.
  • Regal Partners first reported a position in Thermo Fisher Scientific in Q2 2022 and held it in 8 quarters.
  • Regal Partners's Thermo Fisher Scientific position peaked at $5.58M in Q2 2023.
  • 2,542 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Regal Partners's 13F filing for Q2 2024, filed 2 Aug 2024.